Abstract:Introduction Orally disintegrating tablet (ODT) is a dosage form that overcomes the problem of swallowing which is prevalent in about 35% of the general population. Co-trimoxazole (CTX) is given for patients with HIV for the prophylaxis of opportunistic infection (OI), commonly for pneumocystis carinii pneumonia. It was reported that CTX was associated with a 25–46% reduction in mortality among individuals infected with HIV in sub-Saharan Africa. Esophageal candidiasis which usually comes along with HIV/AIDS is one of AIDS defining illness affecting up to 1 in 5 of people with AIDS. This opportunistic illness is manifested by painful or difficulty of swallowing. In this respect, CTX ODT offer the advantages of both liquid dosage forms in terms of easy swallowing thereby improve patient compliance and solid dosage forms in terms of dose uniformity, stability, lower production, and transportation costs. The objective of this study was to formulate, characterize and optimize CTX ODT which could overcome swallowing problem and improve patient compliance. Co-trimoxazole ODTs were prepared by direct compression technique using a semi synthetic super disintegrant (crospovidone) along with other excipients. Two taste masking techniques were employed, addition of sweetening agent, and solid dispersion by using a pH sensitive polymer, Eudragit E-100 at different ratios (1:1, 1:2 and 1:3). Taste masking was determined by comparing taste threshold value and in vitro drug release. Preliminary study was used to investigate the effect of crospovidone, compression force (CF) and Hydroxypropyl cellulose (HPC) on disintegration time, friability and wetting time (WT). Factorial design was used as it enables simultaneous evaluation of formulation variables and their interaction effect. From the preliminary study, the factors that were found significant were further optimized using central composite design. Design-Expert 8.0.7.1 software was employed to carry out the experimental design. The bitterness threshold concentration of Trimethoprim was found to be 150 μg/ml and the in vitro drug release of the three batches of drug to polymer ratio (F1:1, 1:2 and 1:3) was 2.80±0.05, 2.77±0.00 and 2.63±0.00 respectively. From the optimization study, the optimal concentration for the superdisintegrant was 8.60% w/w and a CF of 11.25 KN which gave a rapid disintegration and WT of 13.79 and 23.19 seconds respectively and a friability of 0.666%. Conclusion In this study, co-trimoxazole ODT was formulated successfully. Central composite design was effectively used to model and optimize friability, DT and WT. The method was found effective for estimating the effect of independent variables on the dependent variables by using polynomial equation and surface plots. Optimization of the response variables was possible by using both numerical and graphical optimization and the predicted optimal conditions were confirmed experimentally and were found to be in good agreement within 5% of the predicted responses. The results of the study showed that CTX ODT had significantly rapid disintegration, less than 1% friability and enhanced dissolution profiles. The successful formulation of CTX ODT can solve difficulty of swallowing of conventional tablets for some group of patients which are unable to swallow solid oral dosage form.

The Optimization of Diclofenac Zinc Sustained-Release Tablets Formulation by Orthogonal Test Method

Preparation and Quality Control of Levamlodipine Besylate Orally Disintegrating Tablets

Study on pramipexole dihydrochloride sustained-release tablets

Optimization of the Biphasic Release of Indomethacin from HPMC/pectin/calcium Chloride Matrix Tablet by Response Surface Methodology

Preparation and Optimization of the Formulation of Flupirtine Maleate Orally Disintegrating Tablets

Collecting student feedback: a whole‐school approach

[Arrhythmologic study of 50 patients with arrhythmogenic disease of the right ventricle: prognostic implications].

Comparison of Several Statistic Designs in the Development of Ligustrazine Hydrochloride(tmph) Sustained Release Formulations

Significance and cost effectiveness of pre-operative routine laboratory investigations in young healthy patients undergoing elective ear, nose & throat surgery.

Optimization of formulation for the Qiyuejiangzhi tablets

Optimization of Cudrania Extractum Tablets Formulation by Central Composite Design-Response Surface Methodology

Central Composite Designed Fast Dissolving Tablets for Improved Solubility of the Loaded Drug Ondansetron Hydrochloride

On Formula Optimization for Valaciclovir Dispersible Tablets

Optimization of Breviscapin Sustainded Release Tablets by Mixture Uniform Design

Optimized Preparation of Silymarin Dropping Pill by a Central Composite Design-Response Surface Method

Evaluation of Carbopol 71G and HPMC As Matrix Materials in a Sustained Release Formulation

Oral fast dissolving films for co-administration of breviscapine and matrine: Formulation optimization and in vitro characterization

STATISTICAL DESIGN OF EXPERIMENT-BASED FORMULATION DEVELOPMENT AND OPTIMIZATION OF FLOATING MATRIX TABLET OF ANTI-EMETIC DRUG

Application of the custom design methodology in the buflomedil hydrochloride sustained release tablets formulation

Optimized Formulation of Rizatriptan Benzoate Tablet by a Central Composite Design/Response Surface Methodology

Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression